ENDOCYTE INC (ECYT) Stock Price & Overview

NASDAQ:ECYTUS29269A1025

Current stock price

23.99
-0.01 (-0.04%)
At close:
23.99
0 (0%)
After Hours:

The current stock price of ECYT is 23.99 null. Today ECYT is down by -0.04%. In the past month the price increased by 1.78%. In the past year, price increased by 464.47%.

ECYT Key Statistics

52-Week Range2.81 - 24
Current ECYT stock price positioned within its 52-week range.
1-Month Range23.39 - 24
Current ECYT stock price positioned within its 1-month range.
Market Cap
1.969B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.68
Dividend Yield
N/A

ECYT Stock Performance

Today
-0.04%
1 Week
+0.54%
1 Month
+1.78%
3 Months
+36.85%
Longer-term
6 Months +73.97%
1 Year +464.47%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

ECYT Stock Chart

ENDOCYTE INC / ECYT Daily stock chart

ECYT Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to ECYT. When comparing the yearly performance of all stocks, ECYT is one of the better performing stocks in the market, outperforming 99.72% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ECYT Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ECYT. While ECYT has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ECYT Earnings

Next Earnings DateN/A
Last Earnings DateN/A

ECYT Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y36%
Revenue Next YearN/A

ECYT Financial Highlights

Over the last trailing twelve months ECYT reported a non-GAAP Earnings per Share(EPS) of -0.6799999999999999. The EPS increased by 38.74% compared to the year before.


Income Statements
Revenue(TTM)128.80K
Net Income(TTM)-41.34M
Industry RankSector Rank
PM (TTM) -32095.26%
ROA -11.64%
ROE -11.91%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%43.33%
Sales Q2Q%164.31%
EPS 1Y (TTM)38.74%
Revenue 1Y (TTM)84%

ECYT Ownership

Ownership
Inst Owners75.62%
Shares82.09M
Float73.88M
Ins Owners0.58%
Short Float %N/A
Short RatioN/A

About ECYT

Company Profile

Endocyte, Inc. is a biopharmaceutical company engaged in the development of therapies for the treatment of cancer and inflammatory diseases. The Company creates novel small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized targeted therapies. Endocyte, Inc. is based in West Lafayette, Indiana.

Company Info

ENDOCYTE INC

3000 KENT AVENUE SUITE A1-100

WEST LAFAYETTE IN 47906

CEO: Michael A. Sherman

Phone: 765-463-7175

ENDOCYTE INC / ECYT FAQ

What does ECYT do?

Endocyte, Inc. is a biopharmaceutical company engaged in the development of therapies for the treatment of cancer and inflammatory diseases. The Company creates novel small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized targeted therapies. Endocyte, Inc. is based in West Lafayette, Indiana.


What is the current price of ECYT stock?

The current stock price of ECYT is 23.99 null. The price decreased by -0.04% in the last trading session.


Does ECYT stock pay dividends?

ECYT does not pay a dividend.


What is the ChartMill rating of ENDOCYTE INC stock?

ECYT has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What is the Price/Earnings (PE) ratio of ENDOCYTE INC (ECYT)?

ENDOCYTE INC (ECYT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.68).